SOHC 2002 Cover

The quality-adjusted life years has shown staying power in cost-effectiveness calculations, but some say it has major flaws and have proposed alternatives.

Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.

Gossamer also reported encouraging preclinical data related to the combination of seralutinib and Winrevair.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.

Native Americans face the longest travel times, even after accounting for distances in rural areas, according to results of a recently published cross-sectional study. Lowering transportation barriers could increase screening and early detection.

Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch without the limitations of traditional treatments.